Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients-Reference-Cited by-同舟云学术

Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

Published:1998-07 Issue:8 Volume:34 Page:1193-1197
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Strojan P,Budihna M,Šmid L,Vrhovec I,Škrk J

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Tumour-associated proteases;Schmitt;Fibrinolysis,1992

2. Pappot H, Gårdsvoll H, Rømer J, et al. Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe-Seyler 1995, 376, 259–267.

3. Plasminogen activator in human xenografted oro-pharyngeal squamous cell carcinomas;Björlin;Acta Otolaryngol (Stockh),1987

4. Parolini S, Flagiello D, Cinquetti A, et al. Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx. Br J Cancer 1996, 74, 1168–1174.

5. Clayman G, Wang SW, Nicolson GL, et al. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity. Int J Cancer 1993, 54, 73–80.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Impedimetric Biosensing Strategy Based on BicyclicPeptides as Bioreceptors for Monitoring h-uPA Cancer Biomarkers;Chemosensors;2023-04-09

2. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis;2020-12-23

3. Identification of two core genes in glioblastomas with different isocitrate dehydrogenase mutation status;Molecular Biology Reports;2020-09-11

4. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer;Scientific Reports;2019-02-19

5. Plasminogen activator inhibitor-1 in cancer research;Biomedicine & Pharmacotherapy;2018-09